Punjab Chemicals
Punjab Chemicals Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
3 of 4 strong
Not discussed on this call: fundraise.
The short version
Targeted revenue growth of 15%-20% for FY27, with a stronger H2 expected than H1. Management targets revenue growth of 15%-20% for FY27, especially stronger in H2, driven by a mix of agrochemical and pharmaceutical intermediates (Page 10).
From Punjab Chemicals's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Targeted revenue growth of 15%-20% for FY27, with a stronger H2 expected than H1.
- Q1 saw 8.7% year-on-year revenue growth; exports grew 27.7% while domestic declined marginally by 3.1%.
- New products are expected to contribute 15%-18% of revenue in FY27, growing over time towards 20%+.
- Increased focus on new product commercialization—4 to 5 products expected to launch yearly, with some adding INR40-50 crores each over 3-4 years.
- Expansion in capacity (e.g., new manufacturing block at Lalru and pilot plant revamp) to support growth.
- Growing CDMO business with advanced discussions expected to add 2-3 new customers on multi-year contracts.
- Strong order book visibility for Q2 to Q4 supports medium-term growth confidence.
- Agrochemicals to remain dominant segment (65%-70%) with balanced CDMO and catalog product mix around 50:50.
Profitability & Margins
See what Punjab Chemicals said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Greenfield capex is planned to start in FY27 as a clear goal for long-term growth across agro and specialty chemicals.
- New manufacturing block at the Lalru plant is under construction; civil work has commenced, with major investment in Q2 and Q3 FY27.
- A revamp of the pilot plant is underway, targeting completion by September-October 2026, to increase capacity for simultaneous scale-up of multiple products.
- Expansion of R&D facilities has doubled in size over the last 2 years, enhancing product scale-up and development pipeline.
- Continuous addition of 4-5 new products annually to commercial portfolio, supported by investments in capacity and R&D infrastructure.
- Evaluation ongoing for a new manufacturing site to support incremental growth and product pipeline beyond current facilities.
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Punjab Chemicals said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The order book for the year provides reasonable visibility on existing businesses.
- For Q1, Q2, and part of Q3, there is clear visibility of achieving volumes as per original predictions.
- Management mentioned a strong order position moving forward for Q2 and Q3.
- While a precise breakup between new products and legacy products in the order book wasn't provided, new products are targeted to contribute 15% to 18% of revenue in FY27.
- Several commercial lot supplies have been made for MoU products, with volume ramp-up expected from Q4 FY27.
- The company continues to engage with customers for long-term contracts, especially in Europe, Japan, and domestic markets, indicating ongoing and growing order interest.
- Expansion in R&D and infrastructure aims to support increasing demand and order fulfillment.
Punjab Chemicals — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹209 Cr, net profit ₹11 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Punjab Chemicals's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Indogulf Cropsci (Q1 FY27)
1800+ crores within 2-3 years. Key concall takeaways from Indogulf Cropsciences Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- G S F C (Q1 FY27)
Profit after tax increased by 15% YoY in Q1 FY27, signaling positive growth trajectory. Key concall takeaways from Gujarat State Fertilizers & Chemicals Ltd's…
- GSP Crop Science (Q1 FY27)
Capacity utilization indicates room for growth: 70-75% for technical and 25-30% for formulations. Key concall takeaways from GSP Crop Science Ltd's Q1 FY27…
- Rallis India Ltd (Q1 FY27)
. Key concall takeaways from Rallis India's Q1 FY27 earnings call — and how it ranks against sector peers.
Frequently Asked Questions
What were Punjab Chemicals Q1 FY27 results?
Targeted revenue growth of 15%-20% for FY27, with a stronger H2 expected than H1. Management targets revenue growth of 15%-20% for FY27, especially stronger in H2, driven by a mix of agrochemical and pharmaceutical intermediates (Page 10).
What is Punjab Chemicals share price analysis?
Punjab Chemicals currently shows a below-average growth signal. The stock trades at a P/E of 21.0 with a market cap of ₹1,407 Cr. Investors should review the full earnings analysis for detailed insights.
Is Punjab Chemicals planning capital expenditure?
Greenfield capex is planned to start in FY27 as a clear goal for long-term growth across agro and specialty chemicals.
Keep Punjab Chemicals on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
